Market Access 2023
Market Access 2023
Getting the right treatment, to the right patient, at the right time is the backbone of market access. However, amid global conflicts, supply shortages, economic instability, and regulatory changes, the reality of achieving this goal is often far more complex than it is on paper. Read on for key stories, including the road to DTx harmonisation in Europe, why HRT and menopause treatment access is making waves in the UK, how brands can address plasma shortages, and much more.
Market Access 2023
Getting the right treatment to the right patient at the right time
HIV: Inside 36 years of treatment access
From zero to 30 in just over three decades, the journey from discovery to approval has been a unique process in HIV care. We track the tumultuous path to treatment in the US and abroad.
How to solve a problem like DTx in Europe?
Digital Therapeutics have been praised for their potential in healthcare, yet the path to market remains fragmented. Healthware’s Alberta Spreafico discusses the need for DTx market harmonisation across the EU.
12 questions with: Gerwin Winter
Beigene’s senior vice president and head of Europe, Gerwin Winter, discusses his proudest professional accomplishments, passion to unlock patient access to the best care, and offers a glimpse of his goals for the future.
What the HRT is going on with menopause treatment?
Amid national treatment shortages and growing demand to break the ‘postcode lottery’ of care in the UK, we take a look at the state of menopause treatment in the UK.
CSL opens a new R&D facility
In this photo essay, pharmaphorum editor-in-chief, Jonah Comstock, takes us behind the scenes for a tour of CSL’s new brand-new R&D facility in Waltham, Massachusetts.
How the hyperlocal delivery model could empower pharmacists
In the pharmaceutical industry, there are many innovative technologies at our fingertips that could help to ease NHS challenges, so why has pharma been slow to adopt the hyperlocal delivery model, asks Healistic’s CEO Daniel Bulkin.
12 questions with: Daniel Kohlstaedt
PurpleLeaf Strategy’s managing director, Daniel Kohlstaedt, discusses his experience of working for 18 years in the pharma industry, and why, in an industry of innovation, it’s important to get the basics right.
Video: Plasma – It’s in the blood
Despite being a central ingredient of several lifesaving medications, plasma is in short supply in the EU. But why? pharmaphorum editor-in-chief, Jonah Comstock sits down with Takeda Pharmaceuticals’, Giles Platford, to find out more about the plasma shortfall in the EU.
Building trust in data-driven digital healthcare systems
Trust takes time, but a data-driven digital healthcare system isn’t possible without it. As co-founder of the Privacy Compliance Hub, Nigel Jones, discusses, the NHS needs to find a way to put privacy first to build trust with the public around its innovation plans.
Around the world in pharma events
Keep up to date with important industry events taking place across the pharmaceutical industry with this interactive guide to upcoming conferences around the world
Read Deep Dive: Market Access 2023 in full pharmaphorum’s digital magazine Deep Dive provides objective, issue-driven views, analysis, high-level interviews and unique research for pharmaceutical companies, biotech firms and the wider healthcare sector. Subscribe to future issues of Deep Dive.
